112 related articles for article (PubMed ID: 7092276)
21. Recurrent pyoderma in a family with a defect in leucocyte locomotion.
Zielinski CC; Dremsek PA; Ahmad R; Eibl MM
Br Med J (Clin Res Ed); 1984 Dec; 289(6458):1561-3. PubMed ID: 6439317
[TBL] [Abstract][Full Text] [Related]
22. Suppression of mixed lymphocyte reactivity by cellular and humoral factors in aplastic anemia--both before and after bone marrow transplantation.
Naparstek E; Amar A; Brautbar C
Transplantation; 1983 Oct; 36(4):365-9. PubMed ID: 6226133
[TBL] [Abstract][Full Text] [Related]
23. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
24. Treatment of pyoderma gangrenosum with the anti-TNFalpha drug - Etanercept.
Rogge FJ; Pacifico M; Kang N
J Plast Reconstr Aesthet Surg; 2008; 61(4):431-3. PubMed ID: 18358433
[TBL] [Abstract][Full Text] [Related]
25. Direct immunofluorescence in pyoderma gangrenosum.
Powell FC; Schroeter AL; Perry HO; Su WP
Br J Dermatol; 1983 Mar; 108(3):287-93. PubMed ID: 6338899
[TBL] [Abstract][Full Text] [Related]
26. [Pyoderma gangrenosum--an interdisciplinary diagnostic problem].
Torzecka JD; Kondras K; Dziankowska-Bartkowiak B; Waszczykowska E; Modzelewski B; Jurałowicz P; Kondras M
Pol Merkur Lekarski; 2008 Jan; 24(139):34-7. PubMed ID: 18634250
[TBL] [Abstract][Full Text] [Related]
27. Recurrent pyoderma gangrenosum and agnogenic myeloid metaplasia.
Callen JP; Dubin HV; Gehrke CF
Arch Dermatol; 1977 Nov; 113(11):1585-6. PubMed ID: 931401
[TBL] [Abstract][Full Text] [Related]
28. Immunologic and biochemical studies on a patient with pyoderma gangrenosum.
Asghar SS; Bos JD; Kammeijer A; Cormane RH
Int J Dermatol; 1984 Mar; 23(2):112-6. PubMed ID: 6142008
[TBL] [Abstract][Full Text] [Related]
29. Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis.
Lazarus GS; Goldsmith LA; Rocklin RE; Pinals RS; de Buisseret JP; David JR
Arch Dermatol; 1972 Jan; 105(1):46-51. PubMed ID: 5009622
[No Abstract] [Full Text] [Related]
30. The role of anti-tumor necrosis factor-alpha therapy in Pyoderma gangrenosum associated with inflammatory bowel disease.
Reguiaï Z; Grange F
Am J Clin Dermatol; 2007; 8(2):67-77. PubMed ID: 17428111
[TBL] [Abstract][Full Text] [Related]
31. In vitro assays of cellular immunity in progressive coccidioidomycosis: evaluation of suppression with parasitic-phase antigen.
Harvey RP; Stevens DA
Am Rev Respir Dis; 1981 Jun; 123(6):665-9. PubMed ID: 7271066
[TBL] [Abstract][Full Text] [Related]
32. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.
Brooks WH; Netsky MG; Normansell DE; Horwitz DA
J Exp Med; 1972 Dec; 136(6):1631-47. PubMed ID: 4345108
[TBL] [Abstract][Full Text] [Related]
33. Depressed cell-mediated immunity in chronic dermatophytic infections.
Brahmni Z; Liautaud B; Marill F
Ann Immunol (Paris); 1980; 131C(2):143-53. PubMed ID: 6998354
[TBL] [Abstract][Full Text] [Related]
34. [Pyoderma gangrenosum revealing colonic diverticulitis: Two cases].
Fongue J; Brajon D; Visée C; Combes E; Andrac-Meyer L; Berbis P
Ann Dermatol Venereol; 2015 Nov; 142(11):664-9. PubMed ID: 26372545
[TBL] [Abstract][Full Text] [Related]
35. [Pyoderma gangrenosum and IgA gammopathy. Association with atrophic gastritis].
Carsuzaa F; Pierre C; Dubegny M
Ann Dermatol Venereol; 1989; 116(10):707-13. PubMed ID: 2514619
[TBL] [Abstract][Full Text] [Related]
36. Pyoderma gangrenosum, acne and ulcerative colitis in a patient with a novel mutation in the PSTPIP1 gene.
Zeeli T; Padalon-Brauch G; Ellenbogen E; Gat A; Sarig O; Sprecher E
Clin Exp Dermatol; 2015 Jun; 40(4):367-72. PubMed ID: 25683018
[TBL] [Abstract][Full Text] [Related]
37. Recurrent chronic pyoderma with cellular immunodeficiency. Successful therapy by levamisole.
Djawari D; Hornstein OP
Dermatologica; 1980; 161(2):116-23. PubMed ID: 7398982
[TBL] [Abstract][Full Text] [Related]
38. [Cellular immunity in patients with ulcerous forms of chronic pyoderma undergoing treatment].
Mazina NM; Baltabaev MK
Vestn Dermatol Venerol; 1989; (3):48-51. PubMed ID: 2741546
[TBL] [Abstract][Full Text] [Related]
39. Clinical management of pyoderma gangrenosum.
Wollina U
Am J Clin Dermatol; 2002; 3(3):149-58. PubMed ID: 11978136
[TBL] [Abstract][Full Text] [Related]
40. [Pyoderma gangrenosum (PG) with myeloma IgA lambda and deficiency of cellular immunity].
Sánchez Yus E; Cabré J
Actas Dermosifiliogr; 1980; 71(1-2):35-40. PubMed ID: 7376957
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
